ClinicalTrials.Veeva

Menu

Effect of Protein-Restricted Diet on Nitrogen Balance and Residual Renal Function in Peritoneal Dialysis (PD) Patients

S

Shanghai Jiao Tong University School of Medicine

Status

Completed

Conditions

Chronic Kidney Disease
Peritoneal Dialysis

Treatments

Dietary Supplement: diets contained different levels of protein

Study type

Interventional

Funder types

Other

Identifiers

NCT00633646
05PJ14057(Shanghai, China)

Details and patient eligibility

About

Current therapy recommendations suggest a low protein diet to preserve residual renal function (RRF) before the start of dialysis, but a higher protein intake during dialysis to prevent protein-energy wasting (PEW). We conducted a randomized trial to test whether low protein intake also during treatment with peritoneal dialysis (PD) would be safe and associated with a preserved RRF.

Full description

Dietary protein is the major source of nitrogen excreted as urea by the kidney, and a decreased protein intake has been associated with a retardation of kidney function loss in non-dialysis chronic kidney disease (CKD) patients. While a low protein diet is recommended to end-stage renal disease (ESRD) patients before the start of dialysis to preserve residual renal function(RRF), current therapy recommendations in dialysis are for a normal protein intake of no less than 1.2 g of protein/kg ideal body weight (IBW)/day to prevent protein-energy wasting (PEW).

We hypothesized that a lower protein intake would be safe and able to slow the loss of RRF also in dialysis patients and conducted two prospective, randomized trials involving a total of 94 peritoneal dialysis (PD) patients to test our hypothesis.

Enrollment

94 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 18-80 years
  • stable peritoneal dialysis since at least 1 month
  • with renal function

Exclusion criteria

  • a high probability (assessed by the recruiting physician) of receiving a kidney transplant within one year
  • overt infection within the last month
  • poor compliance in previous dietary prescriptions or irregular check-ups
  • persistent anorexia, vomiting or diarrhea within the last month
  • a CRP of more than 30 mg/dL
  • presence of wasting diseases such as cancer or tuberculosis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

94 participants in 3 patient groups

1
Active Comparator group
Description:
low protein diet
Treatment:
Dietary Supplement: diets contained different levels of protein
2
Active Comparator group
Description:
low protein diet with keto acids
Treatment:
Dietary Supplement: diets contained different levels of protein
3
Active Comparator group
Description:
high protein diet
Treatment:
Dietary Supplement: diets contained different levels of protein

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems